Katherine Fuh, MD, PhD

Title(s)Associate Professor, Ob/Gyn, Reproductive Sciences
SchoolSchool of Medicine
Phone--
vCardDownload vCard

    Collapse ORNG Applications 
    Collapse Clinical Trials

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. ROR2/Wnt5a signaling regulates directional cell migration and early tumor cell invasion in ovarian cancer. Mol Cancer Res. 2024 Feb 09. Grither WR, Baker B, Morikis VA, Ilagan MXG, Fuh KC, Longmore GD. PMID: 38334461.
      View in: PubMed   Mentions:    Fields:    
    2. DDR2-regulated arginase activity in ovarian cancer-associated fibroblasts promotes collagen production and tumor progression. Oncogene. 2024 Jan; 43(3):189-201. Akinjiyan FA, Ibitoye Z, Zhao P, Shriver LP, Patti GJ, Longmore GD, Fuh KC. PMID: 37996700; PMCID: PMC10786713.
      View in: PubMed   Mentions:    Fields:    Translation:HumansAnimalsCells
    3. Epigenetic regulation during cancer transitions across 11 tumour types. Nature. 2023 Nov; 623(7986):432-441. Terekhanova NV, Karpova A, Liang WW, Strzalkowski A, Chen S, Li Y, Southard-Smith AN, Iglesia MD, Wendl MC, Jayasinghe RG, Liu J, Song Y, Cao S, Houston A, Liu X, Wyczalkowski MA, Lu RJ, Caravan W, Shinkle A, Naser Al Deen N, Herndon JM, Mudd J, Ma C, Sarkar H, Sato K, Ibrahim OM, Mo CK, Chasnoff SE, Porta-Pardo E, Held JM, Pachynski R, Schwarz JK, Gillanders WE, Kim AH, Vij R, DiPersio JF, Puram SV, Chheda MG, Fuh KC, DeNardo DG, Fields RC, Chen F, Raphael BJ, Ding L. PMID: 37914932; PMCID: PMC10632147.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCells
    4. Stromal DDR2 Promotes Ovarian Cancer Metastasis through Regulation of Metabolism and Secretion of Extracellular Matrix Proteins. Mol Cancer Res. 2023 11 01; 21(11):1234-1248. Schab AM, Greenwade MM, Stock E, Lomonosova E, Cho K, Grither WR, Noia H, Wilke D, Mullen MM, Hagemann AR, Hagemann IS, Thaker PH, Kuroki LM, McCourt CK, Khabele D, Powell MA, Mutch DG, Zhao P, Shriver LP, Patti GJ, Longmore GD, Fuh KC. PMID: 37527178; PMCID: PMC10832402.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    5. Genetic characterization of primary and metastatic high-grade serous ovarian cancer tumors reveals distinct features associated with survival. Commun Biol. 2023 07 03; 6(1):688. Kotnik EN, Mullen MM, Spies NC, Li T, Inkman M, Zhang J, Martins-Rodrigues F, Hagemann IS, McCourt CK, Thaker PH, Hagemann AR, Powell MA, Mutch DG, Khabele D, Longmore GD, Mardis ER, Maher CA, Miller CA, Fuh KC. PMID: 37400526; PMCID: PMC10318066.
      View in: PubMed   Mentions: 2  Translation:Humans
    6. Reproductive Scientist Development Program: Bridging the Gap to the Physician Scientist Career. Reprod Sci. 2023 09; 30(9):2615-2622. Lo JO, Boniface ER, Heflin A, Stanic-Kostic AK, Fuh KC, Schust DJ. PMID: 37020073; PMCID: PMC10075491.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    7. Visualizing DNA Damage Repair Proteins in Patient-Derived Ovarian Cancer Organoids via Immunofluorescence Assays. J Vis Exp. 2023 02 24; (192). van Biljon L, Fashemi B, Rodriguez J, Graham O, Compadre A, Fuh K, Khabele D, Mullen M. PMID: 36912550; PMCID: PMC10881227.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    8. Generation and Culturing of High-Grade Serous Ovarian Cancer Patient-Derived Organoids. J Vis Exp. 2023 01 06; (191). Graham O, Rodriguez J, van Biljon L, Fashemi B, Graham E, Fuh K, Khabele D, Mullen M. PMID: 36688549; PMCID: PMC10881225.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    9. Identity-related experiences of Asian American trainees in gynecologic oncology. Gynecol Oncol Rep. 2022 Dec; 44:101097. Dholakia J, Lee YW, Lu KH, Huh WK, Yamada SD, Fuh KC, Kumar AS, Liang MI, Nair N, Kim KH. PMID: 36388752; PMCID: PMC9664478.
      View in: PubMed   Mentions:
    10. Community access to primary care is an important geographic disparity among ovarian cancer patients undergoing cytoreductive surgery. Gynecol Oncol Rep. 2022 Dec; 44:101075. Zamorano AS, Mazul AL, Marx C, Mullen MM, Greenwade M, Stewart Massad L, McCourt CK, Hagemann AR, Thaker PH, Fuh KC, Powell MA, Mutch DG, Khabele D, Kuroki LM. PMID: 36217326; PMCID: PMC9547182.
      View in: PubMed   Mentions:
    11. State of the Biomarker Science in Ovarian Cancer: A National Cancer Institute Clinical Trials Planning Meeting Report. JCO Precis Oncol. 2022 Oct; 6:e2200355. Ethier JL, Fuh KC, Arend R, Konecny GE, Konstantinopoulos PA, Odunsi K, Swisher EM, Kohn EC, Zamarin D. PMID: 36240472; PMCID: PMC9848534.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    12. High visceral fat to subcutaneous fat ratios portend a poor prognosis in patients with advanced endometrial cancer. Gynecol Oncol. 2022 Dec; 167(3):496-501. Buckley E, Mullen MM, Nizamuddin RA, Stein JH, Kuroki LM, Fuh KC, Hagemann AR, McCourt CK, Mutch D, Khabele D, Powell MA, Ippolito JE, Thaker PH. PMID: 36180305; PMCID: PMC10836416.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    13. Gynecologic oncology patient perspectives and knowledge on advance care planning: A quality improvement intervention. Gynecol Oncol Rep. 2022 Oct; 43:101060. Huepenbecker SP, Lewis S, Valentine MC, Palisoul ML, Thaker PH, Hagemann AR, McCourt CK, Fuh KC, Powell MA, Mutch DG, Kuroki LM. PMID: 36032812; PMCID: PMC9399146.
      View in: PubMed   Mentions:
    14. GAS6-AXL Inhibition by AVB-500 Overcomes Resistance to Paclitaxel in Endometrial Cancer by Decreasing Tumor Cell Glycolysis. Mol Cancer Ther. 2022 08 02; 21(8):1348-1359. Bruce SF, Cho K, Noia H, Lomonosova E, Stock EC, Oplt A, Blachut B, Mullen MM, Kuroki LM, Hagemann AR, McCourt CK, Thaker PH, Khabele D, Powell MA, Mutch DG, Shriver LP, Patti GJ, Fuh KC. PMID: 35588308; PMCID: PMC9370070.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    15. DDR2 Expression in Cancer-Associated Fibroblasts Promotes Ovarian Cancer Tumor Invasion and Metastasis through Periostin-ITGB1. Cancers (Basel). 2022 Jul 18; 14(14). Akinjiyan FA, Dave RM, Alpert E, Longmore GD, Fuh KC. PMID: 35884543; PMCID: PMC9319689.
      View in: PubMed   Mentions: 6  
    16. Ridiculously good writing: How to write like a pro and publish like a boss. Gynecol Oncol Rep. 2022 Aug; 42:101024. Modesitt SC, Havrilesky LJ, Previs RA, Alejandro Rauh-Hain J, Michael Straughn J, Bakkum-Gamez JN, Fuh KC, Cohn DE. PMID: 35719321; PMCID: PMC9204657.
      View in: PubMed   Mentions:
    17. Mismatch repair deficiency in ovarian cancer. Gynecol Oncol Rep. 2022 Jun; 41:101015. Fuh K. PMID: 35769496; PMCID: PMC9235039.
      View in: PubMed   Mentions:
    18. Impact of the COVID-19 pandemic on referral to and delivery of gynecologic oncology care. Gynecol Oncol Rep. 2022 Feb; 39:100928. Bruce SF, Huysman B, Bharucha J, Massad LS, Mullen MM, Hagemann AR, Fuh KC, McCourt CK, Thaker PH, Khabele D, Powell MA, Mutch DG, Kuroki LM. PMID: 35024405; PMCID: PMC8739812.
      View in: PubMed   Mentions: 3  
    19. Author Correction: Comprehensive characterization of 536 patient-derived xenograft models prioritizes candidates for targeted treatment. Nat Commun. 2022 Jan 07; 13(1):294. Sun H, Cao S, Mashl RJ, Mo CK, Zaccaria S, Wendl MC, Davies SR, Bailey MH, Primeau TM, Hoog J, Mudd JL, Dean DA, Patidar R, Chen L, Wyczalkowski MA, Jayasinghe RG, Rodrigues FM, Terekhanova NV, Li Y, Lim KH, Wang-Gillam A, Van Tine BA, Ma CX, Aft R, Fuh KC, Schwarz JK, Zevallos JP, Puram SV, Dipersio JF, NCI PDXNet Consortium, Davis-Dusenbery B, Ellis MJ, Lewis MT, Davies MA, Herlyn M, Fang B, Roth JA, Welm AL, Welm BE, Meric-Bernstam F, Chen F, Fields RC, Li S, Govindan R, Doroshow JH, Moscow JA, Evrard YA, Chuang JH, Raphael BJ, Ding L. PMID: 34996889; PMCID: PMC8742097.
      View in: PubMed   Mentions:    Fields:    
    20. Culturing Primary Human Mesothelial Cells. Methods Mol Biol. 2022; 2424:147-154. Mullen M, Noia H, Fuh K. PMID: 34918292.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    21. Inhibition of AXL and VEGF-A Has Improved Therapeutic Efficacy in Uterine Serous Cancer. Cancers (Basel). 2021 Nov 23; 13(23). Toboni MD, Lomonosova E, Bruce SF, Tankou JI, Mullen MM, Schab A, Oplt A, Noia H, Wilke D, Kuroki LM, Hagemann AR, McCourt CK, Thaker PH, Powell MA, Khabele D, Mutch DG, Fuh KC. PMID: 34884986; PMCID: PMC8656641.
      View in: PubMed   Mentions: 3  
    22. GAS6/AXL Inhibition Enhances Ovarian Cancer Sensitivity to Chemotherapy and PARP Inhibition through Increased DNA Damage and Enhanced Replication Stress. Mol Cancer Res. 2022 02; 20(2):265-279. Mullen MM, Lomonosova E, Toboni MD, Oplt A, Cybulla E, Blachut B, Zhao P, Noia H, Wilke D, Rankin EB, Kuroki LM, Hagemann AR, Hagemann IS, McCourt CK, Thaker PH, Mutch DG, Powell MA, Mosammaparast N, Vindigni A, Fuh KC. PMID: 34670865; PMCID: PMC8816812.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansAnimalsCells
    23. Phase I Trial of Stereotactic MRI-Guided Online Adaptive Radiation Therapy (SMART) for the Treatment of Oligometastatic Ovarian Cancer. Int J Radiat Oncol Biol Phys. 2022 02 01; 112(2):379-389. Henke LE, Stanley JA, Robinson C, Srivastava A, Contreras JA, Curcuru A, Green OL, Massad LS, Kuroki L, Fuh K, Hagemann A, Mutch D, McCourt C, Thaker P, Powell M, Markovina S, Grigsby PW, Schwarz JK, Chundury A. PMID: 34474109.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansCTClinical Trials
    24. Phase 1b study of AVB-500 in combination with paclitaxel or pegylated liposomal doxorubicin platinum-resistant recurrent ovarian cancer. Gynecol Oncol. 2021 11; 163(2):254-261. Fuh KC, Bookman MA, Liu JF, Coleman RL, Herzog TJ, Thaker PH, Monk BJ, Anderson R, McIntyre G, Rangwala R, Moore KN. PMID: 34474927.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansCTClinical Trials
    25. Comprehensive characterization of 536 patient-derived xenograft models prioritizes candidatesfor targeted treatment. Nat Commun. 2021 08 24; 12(1):5086. Sun H, Cao S, Mashl RJ, Mo CK, Zaccaria S, Wendl MC, Davies SR, Bailey MH, Primeau TM, Hoog J, Mudd JL, Dean DA, Patidar R, Chen L, Wyczalkowski MA, Jayasinghe RG, Rodrigues FM, Terekhanova NV, Li Y, Lim KH, Wang-Gillam A, Van Tine BA, Ma CX, Aft R, Fuh KC, Schwarz JK, Zevallos JP, Puram SV, Dipersio JF, NCI PDXNet Consortium, Davis-Dusenbery B, Ellis MJ, Lewis MT, Davies MA, Herlyn M, Fang B, Roth JA, Welm AL, Welm BE, Meric-Bernstam F, Chen F, Fields RC, Li S, Govindan R, Doroshow JH, Moscow JA, Evrard YA, Chuang JH, Raphael BJ, Ding L. PMID: 34429404; PMCID: PMC8384880.
      View in: PubMed   Mentions: 41     Fields:    Translation:HumansAnimalsCells
    26. Cancer-associated mesothelial cells promote ovarian cancer chemoresistance through paracrine osteopontin signaling. J Clin Invest. 2021 08 16; 131(16). Qian J, LeSavage BL, Hubka KM, Ma C, Natarajan S, Eggold JT, Xiao Y, Fuh KC, Krishnan V, Enejder A, Heilshorn SC, Dorigo O, Rankin EB. PMID: 34396988; PMCID: PMC8363279.
      View in: PubMed   Mentions: 33     Fields:    Translation:HumansAnimalsCells
    27. Text-message-based behavioral weight loss for endometrial cancer survivors with obesity: A randomized controlled trial. Gynecol Oncol. 2021 09; 162(3):770-777. Zamorano AS, Wilson EM, Liu J, Leon A, Kuroki LM, Thaker PH, McCourt CK, Fuh KC, Powell MA, Mutch DG, Evanoff BA, Colditz GA, Hagemann AR. PMID: 34140179.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    28. Radiation therapy for vaginal and perirectal lesions in recurrent ovarian cancer. Gynecol Oncol Rep. 2021 Aug; 37:100808. Johns EA, Stanley JA, Toboni MD, Schwarz JK, Zhang F, Hagemann AR, Fuh KC, Thaker PH, McCourt CK, Mutch DG, Powell MA, Khabele D, Kuroki LM. PMID: 34169134; PMCID: PMC8207207.
      View in: PubMed   Mentions: 1  
    29. Entinostat, a selective HDAC1/2 inhibitor, potentiates the effects of olaparib in homologous recombination proficient ovarian cancer. Gynecol Oncol. 2021 07; 162(1):163-172. Gupta VG, Hirst J, Petersen S, Roby KF, Kusch M, Zhou H, Clive ML, Jewell A, Pathak HB, Godwin AK, Wilson AJ, Crispens MA, Cybulla E, Vindigni A, Fuh KC, Khabele D. PMID: 33867143; PMCID: PMC8647995.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansAnimalsCells
    30. A deficit-accumulation frailty index predicts survival outcomes in patients with gynecologic malignancy. Gynecol Oncol. 2021 06; 161(3):700-704. Mullen MM, McKinnish TR, Fiala MA, Zamorano AS, Kuroki LM, Fuh KC, Hagemann AR, McCourt CK, Mutch DG, Powell MA, Wildes TM, Thaker PH. PMID: 33648746; PMCID: PMC8859805.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    31. Obese endometrial cancer survivors' perceptions of weight loss strategies and characteristics that may influence participation in behavioral interventions. Gynecol Oncol Rep. 2021 May; 36:100719. Wilson EM, Zamorano AS, Liu J, Morris D, Leon A, Kuroki LM, Thaker PH, McCourt CK, Fuh KC, Powell MA, Mutch DG, Colditz GA, Hagemann AR. PMID: 33665293; PMCID: PMC7907756.
      View in: PubMed   Mentions: 2  
    32. Impact of employment and insurance status on distress in gynecologic oncology patients. Gynecol Oncol. 2021 05; 161(2):477-482. Kuroki LM, Morris DH, Greenwade M, Landon M, Hagemann AR, Thaker PH, Massad LS, McCourt CK, Fuh KC, Powell MA, Mutch DG, Khabele D, Vanderlan JR. PMID: 33546868; PMCID: PMC8642034.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    33. The role of endometrial sampling for surveillance of recurrence in postmenopausal patients with medically inoperable stage I endometrial cancer. Gynecol Oncol Rep. 2021 Feb; 35:100694. Carey-Love A, Mullen MM, Zamorano A, Markovina S, Hagemann AR, Fuh KC, Thaker PH, Mutch DG, Powell MA, Kuroki LM. PMID: 33490354; PMCID: PMC7809387.
      View in: PubMed   Mentions:
    34. Clinical assays for assessment of homologous recombination DNA repair deficiency. Gynecol Oncol. 2020 12; 159(3):887-898. Stover EH, Fuh K, Konstantinopoulos PA, Matulonis UA, Liu JF. PMID: 33012552.
      View in: PubMed   Mentions: 45     Fields:    Translation:HumansCells
    35. Homologous recombination deficiency real-time clinical assays, ready or not? Gynecol Oncol. 2020 12; 159(3):877-886. Fuh K, Mullen M, Blachut B, Stover E, Konstantinopoulos P, Liu J, Matulonis U, Khabele D, Mosammaparast N, Vindigni A. PMID: 32967790.
      View in: PubMed   Mentions: 32     Fields:    Translation:HumansCells
    36. Detection of a somatic GREB1-NCOA1 gene fusion in a uterine tumor resembling ovarian sex cord tumor (UTROSCT). Gynecol Oncol Rep. 2020 Nov; 34:100636. Grither WR, Dickson BC, Fuh KC, Hagemann IS. PMID: 32964092; PMCID: PMC7490989.
      View in: PubMed   Mentions: 5  
    37. A fellow-run clinic achieves similar patient outcomes as faculty clinics: A safe and feasible model for gynecologic oncology fellow education. Gynecol Oncol. 2020 10; 159(1):209-213. Buchanan TR, Johns EA, Massad LS, Dick R, Thaker PH, Hagemann AR, Fuh KC, McCourt CK, Powell MA, Mutch DG, Kuroki LM. PMID: 32694061; PMCID: PMC8142030.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    38. FIGO 2018 staging criteria for cervical cancer: Impact on stage migration and survival. Gynecol Oncol. 2020 06; 157(3):639-643. Grigsby PW, Massad LS, Mutch DG, Powell MA, Thaker PH, McCourt C, Hagemann A, Fuh K, Kuroki L, Schwarz JK, Markovina S, Lin AJ, Dehdashti F, Siegel BA. PMID: 32248993.
      View in: PubMed   Mentions: 35     Fields:    Translation:Humans
    39. Proteogenomic Characterization of Endometrial Carcinoma. Cell. 2020 02 20; 180(4):729-748.e26. Dou Y, Kawaler EA, Cui Zhou D, Gritsenko MA, Huang C, Blumenberg L, Karpova A, Petyuk VA, Savage SR, Satpathy S, Liu W, Wu Y, Tsai CF, Wen B, Li Z, Cao S, Moon J, Shi Z, Cornwell M, Wyczalkowski MA, Chu RK, Vasaikar S, Zhou H, Gao Q, Moore RJ, Li K, Sethuraman S, Monroe ME, Zhao R, Heiman D, Krug K, Clauser K, Kothadia R, Maruvka Y, Pico AR, Oliphant AE, Hoskins EL, Pugh SL, Beecroft SJI, Adams DW, Jarman JC, Kong A, Chang HY, Reva B, Liao Y, Rykunov D, Colaprico A, Chen XS, Czekanski A, Jedryka M, Matkowski R, Wiznerowicz M, Hiltke T, Boja E, Kinsinger CR, Mesri M, Robles AI, Rodriguez H, Mutch D, Fuh K, Ellis MJ, DeLair D, Thiagarajan M, Mani DR, Getz G, Noble M, Nesvizhskii AI, Wang P, Anderson ML, Levine DA, Smith RD, Payne SH, Ruggles KV, Rodland KD, Ding L, Zhang B, Liu T, Fenyö D, Clinical Proteomic Tumor Analysis Consortium. PMID: 32059776; PMCID: PMC7233456.
      View in: PubMed   Mentions: 175     Fields:    Translation:HumansAnimalsCells
    40. Low rates of cascade genetic testing among families with hereditary gynecologic cancer: An opportunity to improve cancer prevention. Gynecol Oncol. 2020 01; 156(1):140-146. Griffin NE, Buchanan TR, Smith SH, Leon AA, Meyer MF, Liu J, Tabak RG, Fuh KC, Thaker PH, Powell MA, Mutch DG, Massad LS, Colditz GA, Hagemann AR. PMID: 31780235.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    41. S100A10 Is a Critical Mediator of GAS6/AXL-Induced Angiogenesis in Renal Cell Carcinoma. Cancer Res. 2019 11 15; 79(22):5758-5768. Xiao Y, Zhao H, Tian L, Nolley R, Diep AN, Ernst A, Fuh KC, Miao YR, von Eyben R, Leppert JT, Brooks JD, Peehl DM, Giaccia AJ, Rankin EB. PMID: 31585940; PMCID: PMC7015045.
      View in: PubMed   Mentions: 30     Fields:    Translation:HumansAnimalsCells
    42. Differences in presentation and survival of Asians compared to Caucasians with ovarian cancer: An NRG Oncology/GOG Ancillary study of 7914 patients. Gynecol Oncol. 2019 08; 154(2):420-425. Fuh KC, Java JJ, Chan JK, Kapp DS, Monk BJ, Burger RA, Young RC, Alberts DS, McGuire WP, Markman M, Bell J, Ozols RF, Armstrong DK, Aghajanian C, Bookman MA, Mannel RS. PMID: 31229298; PMCID: PMC6941471.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    43. Type II endometrial cancers with minimal, non-invasive residual disease on final pathology: What should we do next? Gynecol Oncol Rep. 2019 Aug; 29:20-24. Mills KA, Lopez H, Sun L, Cripe JC, Litz T, Thaker PH, Powell MA, Mutch DG, Fuh KC. PMID: 31193699; PMCID: PMC6541758.
      View in: PubMed   Mentions: 2  
    44. Do gynecologic oncology patients with severely diminished renal function and urinary tract obstruction benefit from ureteral stenting or percutaneous nephrostomy? Gynecol Oncol Rep. 2019 May; 28:136-140. Liang B, Lange SS, Massad LS, Dick R, Mills KA, Hagemann AR, McCourt CK, Thaker PH, Fuh KC, Mutch DG, Powell MA, Kuroki LM. PMID: 31061871; PMCID: PMC6488532.
      View in: PubMed   Mentions: 3  
    45. p5RHH nanoparticle-mediated delivery of AXL siRNA inhibits metastasis of ovarian and uterine cancer cells in mouse xenografts. Sci Rep. 2019 03 18; 9(1):4762. Mills KA, Quinn JM, Roach ST, Palisoul M, Nguyen M, Noia H, Guo L, Fazal J, Mutch DG, Wickline SA, Pan H, Fuh KC. PMID: 30886159; PMCID: PMC6423014.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansAnimalsCells
    46. Collagen Remodeling in the Hypoxic Tumor-Mesothelial Niche Promotes Ovarian Cancer Metastasis. Cancer Res. 2019 05 01; 79(9):2271-2284. Natarajan S, Foreman KM, Soriano MI, Rossen NS, Shehade H, Fregoso DR, Eggold JT, Krishnan V, Dorigo O, Krieg AJ, Heilshorn SC, Sinha S, Fuh KC, Rankin EB. PMID: 30862717; PMCID: PMC6822898.
      View in: PubMed   Mentions: 49     Fields:    Translation:HumansAnimalsCells
    47. Inpatient management of hypercalcemia portends a poor prognosis among gynecologic oncology patients: A trigger to initiate hospice care? Gynecol Oncol Rep. 2019 May; 28:1-5. Cripe JC, Buchanan TR, Wan L, Hagemann AR, McCourt CK, Massad LS, Fuh KC, Mutch DG, Powell MA, Thaker PH, Kuroki LM. PMID: 30733991; PMCID: PMC6357846.
      View in: PubMed   Mentions: 1  
    48. Association between body mass index and surgical menopausal symptoms in patients with early stage endometrial cancer. Gynecol Oncol. 2019 04; 153(1):123-126. Cripe JC, Buchanan TR, Kuroki LM, Wan L, Mills KA, Massad L, Hagemann AR, Fuh KC, Mutch DG, Powell MA, Matsuo K, Thaker PH. PMID: 30651188; PMCID: PMC7528438.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    49. Gynecol Oncol Rep. 2019 Feb; 27:31-34. Huepenbecker SP, Wan L, Leon A, Rosen D, Hoff J, Kuroki LM, Fuh KC, Powell MA, Mutch DG, Colditz GA, Hagemann AR. PMID: 30582746; PMCID: PMC6299124.
      View in: PubMed   Mentions: 6  
    50. Therapeutic Inhibition of the Receptor Tyrosine Kinase AXL Improves Sensitivity to Platinum and Taxane in Ovarian Cancer. Mol Cancer Ther. 2019 02; 18(2):389-398. Quinn JM, Greenwade MM, Palisoul ML, Opara G, Massad K, Guo L, Zhao P, Beck-Noia H, Hagemann IS, Hagemann AR, McCourt CK, Thaker PH, Powell MA, Mutch DG, Fuh KC. PMID: 30478151; PMCID: PMC6363844.
      View in: PubMed   Mentions: 23     Fields:    Translation:HumansAnimalsCells
    51. SQ1274, a novel microtubule inhibitor, inhibits ovarian and uterine cancer cell growth. Gynecol Oncol. 2018 11; 151(2):337-344. Mills KA, Roach ST, Quinn JM, Guo L, Beck HM, Lomonosova E, Ilivicky AR, Starks CM, Lawrence JA, Hagemann AR, McCourt C, Thaker PH, Powell MA, Mutch DG, Fuh KC. PMID: 30190114; PMCID: PMC6345644.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansAnimalsCells
    52. Gynecologic Oncologists' Perceptions of Palliative Care and Associated Barriers: A Survey of the Society of Gynecologic Oncology. Gynecol Obstet Invest. 2019; 84(1):50-55. Cripe JC, Mills KA, Kuroki LK, Wan L, Hagemann AR, Fuh KC, Mutch DG, Powell MA, Thaker PH. PMID: 30099446.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    53. TWIST1 induces expression of discoidin domain receptor 2 to promote ovarian cancer metastasis. Oncogene. 2018 03; 37(13):1714-1729. Grither WR, Divine LM, Meller EH, Wilke DJ, Desai RA, Loza AJ, Zhao P, Lohrey A, Longmore GD, Fuh KC. PMID: 29348456; PMCID: PMC5876071.
      View in: PubMed   Mentions: 31     Fields:    Translation:HumansAnimalsCells
    54. Inhibition of the Receptor Tyrosine Kinase AXL Restores Paclitaxel Chemosensitivity in Uterine Serous Cancer. Mol Cancer Ther. 2017 Dec; 16(12):2881-2891. Palisoul ML, Quinn JM, Schepers E, Hagemann IS, Guo L, Reger K, Hagemann AR, McCourt CK, Thaker PH, Powell MA, Mutch DG, Fuh KC. PMID: 28904132; PMCID: PMC5716844.
      View in: PubMed   Mentions: 18     Fields:    Translation:HumansAnimals
    55. Recent Advances in Understanding, Diagnosing, and Treating Ovarian Cancer. F1000Res. 2017; 6:84. Mills K, Fuh K. PMID: 28184293; PMCID: PMC5288682.
      View in: PubMed   Mentions: 11     Fields:    
    56. AXL modulates extracellular matrix protein expression and is essential for invasion and metastasis in endometrial cancer. Oncotarget. 2016 Nov 22; 7(47):77291-77305. Divine LM, Nguyen MR, Meller E, Desai RA, Arif B, Rankin EB, Bligard KH, Meyerson C, Hagemann IS, Massad M, Thaker PH, Hagemann AR, McCourt CK, Powell MA, Mutch DG, Fuh KC. PMID: 27764792; PMCID: PMC5340229.
      View in: PubMed   Mentions: 20     Fields:    Translation:HumansAnimalsCells
    57. Radiation Therapy for Recurrent Clear-Cell Cancer of the Ovary. Int J Gynecol Cancer. 2016 11; 26(9):1608-1614. Westhoff GL, Fuh KC, Longacre TA, McNally JL, Hsu IC, Kapp DS, Teng N, Chen LM. PMID: 27575628.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    58. The association between timing of initiation of adjuvant therapy and the survival of early stage ovarian cancer patients - An analysis of NRG Oncology/Gynecologic Oncology Group trials. Gynecol Oncol. 2016 Dec; 143(3):490-495. Chan JK, Java JJ, Fuh K, Monk BJ, Kapp DS, Herzog T, Bell J, Young R. PMID: 27771168; PMCID: PMC5728987.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    59. Summary of the 2016 American Association for Cancer Research (AACR) Annual Meeting. Gynecol Oncol. 2016 07; 142(1):9-12. Fuh K, Vlad AM, Landen CN. PMID: 27181388.
      View in: PubMed   Mentions:    Fields:    Translation:HumansAnimals
    60. Comparison of bevacizumab alone or with chemotherapy in recurrent ovarian cancer patients. Gynecol Oncol. 2015 Dec; 139(3):413-8. Fuh KC, Secord AA, Bevis KS, Huh W, ElNaggar A, Blansit K, Previs R, Tillmanns T, Kapp DS, Chan JK. PMID: 26144600.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    61. Survival differences of Asian and Caucasian epithelial ovarian cancer patients in the United States. Gynecol Oncol. 2015 Mar; 136(3):491-7. Fuh KC, Shin JY, Kapp DS, Brooks RA, Ueda S, Urban RR, Chen LM, Chan JK. PMID: 25455734.
      View in: PubMed   Mentions: 35     Fields:    Translation:Humans
    62. Direct regulation of GAS6/AXL signaling by HIF promotes renal metastasis through SRC and MET. Proc Natl Acad Sci U S A. 2014 Sep 16; 111(37):13373-8. Rankin EB, Fuh KC, Castellini L, Viswanathan K, Finger EC, Diep AN, LaGory EL, Kariolis MS, Chan A, Lindgren D, Axelson H, Miao YR, Krieg AJ, Giaccia AJ. PMID: 25187556; PMCID: PMC4169907.
      View in: PubMed   Mentions: 147     Fields:    Translation:HumansCells
    63. Concomitant chemotherapy and radiation for the treatment of advanced-stage endometrial cancer. Gynecol Oncol. 2014 Jul; 134(1):24-8. Wilkinson-Ryan I, Binder PS, Pourabolghasem S, Al-Hammadi N, Fuh K, Hagemann A, Thaker P, Schwarz J, Grigsby P, Mutch D, Powell M. PMID: 24823648.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    64. Utilization of and charges for robotic versus laparoscopic versus open surgery for endometrial cancer. J Surg Oncol. 2013 May; 107(6):653-8. Yu X, Lum D, Kiet TK, Fuh KC, Orr J, Brooks RA, Ueda SM, Chen LM, Kapp DS, Chan JK. PMID: 23129514.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    65. Current management of vulvar cancer. Hematol Oncol Clin North Am. 2012 Feb; 26(1):45-62. Fuh KC, Berek JS. PMID: 22244661.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    66. AXL is an essential factor and therapeutic target for metastatic ovarian cancer. Cancer Res. 2010 Oct 01; 70(19):7570-9. Rankin EB, Fuh KC, Taylor TE, Krieg AJ, Musser M, Yuan J, Wei K, Kuo CJ, Longacre TA, Giaccia AJ. PMID: 20858715; PMCID: PMC3408227.
      View in: PubMed   Mentions: 108     Fields:    Translation:HumansAnimalsCells
    67. Oral misoprostol and vaginal isosorbide mononitrate for labor induction: a randomized controlled trial. Obstet Gynecol. 2010 Jul; 116(1):121-126. Collingham JP, Fuh KC, Caughey AB, Pullen KM, Lyell DJ, El-Sayed YY. PMID: 20567177.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    68. Daily compared with 8-hour gentamicin for the treatment of intrapartum chorioamnionitis: a randomized controlled trial. Obstet Gynecol. 2010 Feb; 115(2 Pt 1):344-349. Lyell DJ, Pullen K, Fuh K, Zamah AM, Caughey AB, Benitz W, El-Sayed YY. PMID: 20093909.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    69. The treatment and outcomes of early-stage epithelial ovarian cancer: have we made any progress? Br J Cancer. 2008 Apr 08; 98(7):1191-6. Chan J, Fuh K, Shin J, Cheung M, Powell C, Chen LM, Kapp D, Osann K. PMID: 18349835; PMCID: PMC2359639.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    70. Mesenteric hemodynamic response to circulatory shock. Curr Opin Crit Care. 2003 Apr; 9(2):127-32. Ceppa EP, Fuh KC, Bulkley GB. PMID: 12657975.
      View in: PubMed   Mentions: 36     Fields:    Translation:Humans
    71. Signal transduction by reactive oxygen species: alternative paradigms for signaling specificity. Surgery. 2002 Jun; 131(6):601-12. Fuh KC, Meneshian A, Patel CB, Takiar V, Bulkley GB. PMID: 12075172.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCells
    72. The mesenteric hemodynamic response to circulatory shock: an overview. Shock. 2001 May; 15(5):329-43. Reilly PM, Wilkins KB, Fuh KC, Haglund U, Bulkley GB. PMID: 11336191.
      View in: PubMed   Mentions: 48     Fields:    Translation:HumansAnimals
    73. Hemodynamic pathogenesis of ischemic hepatic injury following cardiogenic shock/resuscitation. Shock. 2000 Oct; 14(4):451-9. Bailey RW, Brengman ML, Fuh KC, Hamilton SR, Herlong HF, Bulkley GB. PMID: 11049109.
      View in: PubMed   Mentions: 3     Fields:    Translation:Animals
    74. Mesenteric vasoconstriction in response to hemorrhagic shock. Shock. 2000; 13(4):267-73. Toung T, Reilly PM, Fuh KC, Ferris R, Bulkley GB. PMID: 10774614.
      View in: PubMed   Mentions: 20     Fields:    Translation:Animals
    75. Endothelial cells potentiate phagocytic killing by macrophages via platelet-activating factor release. Am J Physiol Heart Circ Physiol. 2000 Jan; 278(1):H269-76. Owaki T, Meneshian A, Maemura K, Takao S, Wang D, Fuh KC, Bulkley GB, Klein AS. PMID: 10644608.
      View in: PubMed   Mentions: 4     Fields:    Translation:AnimalsCells
    With one click, see people who:

    Mentor Faculty

    Run Clinical Trials

    Work in Global Health Equity

    Offer Student Projects

    See more options in the Advanced Search tab

    Katherine's Networks
    Concepts (326)
    Derived automatically from this person's publications.
    Explore
    _
    Co-Authors (10)
    People in Profiles who have published with this person.
    Explore
    _
    Similar People (60)
    People who share similar concepts with this person.
    Explore
    _
    Same Department
    Search Department
    _

    UCSF Profiles is managed by the UCSF Clinical and Translational Science Institute (CTSI), part of the Clinical and Translational Science Award program funded by the National Center for Advancing Translational Sciences (Grant Number UL1 TR000004) at the National Institutes of Health (NIH).

    We use cookies to operate our website. We also use cookies to analyze our site’s performance and improve your experience on our site. For more information about how we use cookies, please see our Website Terms of Use. This site is running Profiles RNS version UCSF-v3.1.0-3-g1ef1264b on PROFILES-PWEB03.

    Copyright © The Regents of the University of California.